NSE: JYOTHYLAB | BSE: 532926

Slowing Down Stock

Download real time

254.65 -2.00 (-0.78%)

New 52W Low today

472.1K NSE+BSE Volume

NSE 16 Jan, 2026 3:31 PM (IST)

9,351.1

Market Cap

Below industry Median

Beta 1Year

Very Low volatility

Analyst Downgrade

Geojit BNP downgrades Jyothi Labs to an 'Accumulate' call, expects revenue CAGR of 7% over FY26-27 See details

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Search Inside the pdf :

Jyothy Labs Ltd.

13 Jan 2026

254.65

-0.78%

JYOTHY LABS LIMITED

Accumulate: Jyothy Labs Ltd.

Recommendation Target

Geojit BNP Paribas

ease and festive demand kicks in. Margin trajectory should improve in H2FY26, supported by stable commodity prices, normalization of pricing actions, and scaling of premium launches. The company's innovation pipeline, including Dr. Wool and Ujala Young & Fresh, along with strong...

Jyothy Labs has lost -26.62% in the last 6 Months

Jyothy Labs Ltd.

13 Nov 2025

254.65

-0.78%

Result Update:Jyothy Labs

Hold: Jyothy Labs Ltd.

Target

Axis Direct

Considering the near-term challenges, we maintain our HOLD rating on the stock and revise our TP to Rs 320/share. The TP implies an upside potential of 3% from the CMP.

Jyothy Labs has lost -35.15% in the last 1 Year

Jyothy Labs Ltd.

13 Nov 2025

254.65

-0.78%

Short-term disruption; recovery on track

Buy: Jyothy Labs Ltd.

Target

ICICI Securities Limited

JYL’s Q2FY26 performance was impacted by GST-led disruption and pricing/grammage adjustments (value/volume growth of 0.4%/2.8% YoY).

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

12 Nov 2025

254.65

-0.78%

Weak performance continues; margins under pressure

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

Jyothy Laboratories (JYL) posted flat YoY sales growth in 2QFY26, with volumes rising 3% (est. 4%; 1QFY26 4%). The difference between value and volume growth was primarily due to MRP reductions, higher grammage, and promotional price-offs in select categories.

Jyothy Labs has lost -26.62% in the last 6 Months

Jyothy Labs Ltd.

22 Aug 2025

254.65

-0.78%

JYOTHY LABS LIMITED

Buy: Jyothy Labs Ltd.

Recommendation Target

Geojit BNP Paribas

JLL delivered a modest Q1FY26 performance amid a challenging demand environ- Gross margin contracted 280bps YoY to 48.5%, due to input cost pressures and heightened competition in the Dish wash segment. EBITDA margin stood at 16.5%,...

Geojit BNP Paribas downgraded Jyothy Labs Ltd. to Accumulate with a price target of 306.0 on 13 Jan, 2026.

Jyothy Labs Ltd.

13 Aug 2025

254.65

-0.78%

Result Update:Jyothy Labs

Hold: Jyothy Labs Ltd.

Recommendation Target

Axis Direct

Considering the near-term challenges, we have downgraded the stock from BUY to HOLD and revised our TP to Rs 355/share, implying an upside potential of 7% from the CMP.

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

13 Aug 2025

254.65

-0.78%

Passing clouds in the monsoon season

Buy: Jyothy Labs Ltd.

Target

ICICI Securities Limited

JYL’s Q1FY26 performance was subdued with revenue/ volume growth of 1.4%/ 3.6% YoY impacted by heightened competitive intensity across segments.

Jyothy Labs has lost -35.15% in the last 1 Year

Jyothy Labs Ltd.

27 May 2025

254.65

-0.78%

JYOTHY LABS LIMITED

Accumulate: Jyothy Labs Ltd.

Recommendation Target

Geojit BNP Paribas

Geojit BNP Paribas downgraded Jyothy Labs Ltd. to Accumulate with a price target of 306.0 on 13 Jan, 2026.

Jyothy Labs Ltd.

21 May 2025

254.65

-0.78%

Muted Q4; eyeing gradual recovery

Buy: Jyothy Labs Ltd.

Target

Sharekhan

Q4FY25 was yet another muted quarter for JLL amid subdued demand and higher competitive intensity hit revenue growth, while inflation in key input prices impacted profitability.

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

12 May 2025

254.65

-0.78%

Subdued performance; commentary remains muted

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

Jyothy Laboratories (JYL) reported 1% YoY sales growth (below our est.) in 4QFY25. Volume growth was 4% (est. 7%, 8% in 3QFY25). The gap between volume and value growth was due to higher grammage and promotional price subs in select categories.

Jyothy Labs has lost -35.15% in the last 1 Year

Is Jyothy Labs Ltd. worth buying?

293 Votes:

Buy 81.23%

Sell 11.26%

Hold 7.51%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf